death

Biotech

Veru wraps up COVID trial early and heads to regulators

Veru has wrapped up a phase 3 trial of its COVID treatment early after interim data found it reduced deaths among the sickest COVID patients by 55%.
Max Bayer Apr 11, 2022 10:30am

FDA stops Kura's early-phase leukemia trial after patient dies

Nov 24, 2021 9:55am

Alnylam halts fitusiran trials after patient with hemophilia dies

Sep 7, 2017 11:00am

Investors spooked by Kite CAR-T death, but biotech is confident

May 8, 2017 12:17pm

Hanmi hit over failure to disclose olmutinib cancer trial side effect

Apr 17, 2017 8:31am

Despite deaths and trial halts, Leerink sees Juno positives

Feb 16, 2017 4:36am